Serotonin reuptake inhibitors and bone health: A review of clinical studies and plausible mechanisms

Selective serotonin reuptake inhibitors (SSRIs) are currently the treatment of choice in depression and constitute major portion of prescription in depressive patients. The role of serotonin receptors in bone is emerging, raising certain questions regarding the effect of blockade of serotonin reupta...

Descripción completa

Detalles Bibliográficos
Autores principales: Wadhwa, Ravisha, Kumar, Manoj, Talegaonkar, Sushama, Vohora, Divya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Osteoporosis 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6372777/
https://www.ncbi.nlm.nih.gov/pubmed/30775508
http://dx.doi.org/10.1016/j.afos.2017.05.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6372777/
https://www.ncbi.nlm.nih.gov/pubmed/30775508
http://dx.doi.org/10.1016/j.afos.2017.05.002

Ejemplares similares